South Korea · Delayed Price · Currency is KRW Prestige BioPharma Statistics
Total Valuation
KRX:950210 has a market cap or net worth of KRW 46.75 billion. The enterprise value is 159.90 billion.
| Market Cap | 46.75B |
| Enterprise Value | 159.90B |
Important Dates
The next estimated earnings date is Friday, November 27, 2026.
| Earnings Date | Nov 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KRX:950210 has 12.02 million shares outstanding.
| Current Share Class | n/a |
| Shares Outstanding | 12.02M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.85 |
| PB Ratio | 0.10 |
| P/TBV Ratio | 0.12 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.19 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.75, with a Debt / Equity ratio of 0.21.
| Current Ratio | 0.75 |
| Quick Ratio | 0.48 |
| Debt / Equity | 0.21 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -13.50 |
Financial Efficiency
Return on equity (ROE) is -24.27% and return on invested capital (ROIC) is -16.64%.
| Return on Equity (ROE) | -24.27% |
| Return on Assets (ROA) | -7.87% |
| Return on Invested Capital (ROIC) | -16.64% |
| Return on Capital Employed (ROCE) | -15.75% |
| Weighted Average Cost of Capital (WACC) | 5.75% |
| Revenue Per Employee | 407.37M |
| Profits Per Employee | -1.43B |
| Employee Count | 64 |
| Asset Turnover | 0.04 |
| Inventory Turnover | 1.42 |
Taxes
| Income Tax | -151.60M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -68.81% in the last 52 weeks. The beta is 0.53, so KRX:950210's price volatility has been lower than the market average.
| Beta (5Y) | 0.53 |
| 52-Week Price Change | -68.81% |
| 50-Day Moving Average | 5,828.90 |
| 200-Day Moving Average | 7,952.53 |
| Relative Strength Index (RSI) | 13.64 |
| Average Volume (20 Days) | 78,343 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:950210 had revenue of KRW 26.07 billion and -91.50 billion in losses. Loss per share was -1,522.60.
| Revenue | 26.07B |
| Gross Profit | -16.23B |
| Operating Income | -93.42B |
| Pretax Income | -123.05B |
| Net Income | -91.50B |
| EBITDA | -60.67B |
| EBIT | -93.42B |
| Loss Per Share | -1,522.60 |
Balance Sheet
The company has 65.95 billion in cash and 106.73 billion in debt, with a net cash position of -40.78 billion or -3,392.86 per share.
| Cash & Cash Equivalents | 65.95B |
| Total Debt | 106.73B |
| Net Cash | -40.78B |
| Net Cash Per Share | -3,392.86 |
| Equity (Book Value) | 504.40B |
| Book Value Per Share | 7,188.63 |
| Working Capital | -36.19B |
Cash Flow
In the last 12 months, operating cash flow was -55.82 billion and capital expenditures -5.97 billion, giving a free cash flow of -61.79 billion.
| Operating Cash Flow | -55.82B |
| Capital Expenditures | -5.97B |
| Depreciation & Amortization | 32.76B |
| Net Borrowing | -49.90B |
| Free Cash Flow | -61.79B |
| FCF Per Share | -5,140.95 |
Margins
| Gross Margin | -62.26% |
| Operating Margin | -358.33% |
| Pretax Margin | -471.95% |
| Profit Margin | n/a |
| EBITDA Margin | -232.69% |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
KRX:950210 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -39.14% |
| FCF Yield | -127.88% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KRX:950210 has an Altman Z-Score of -0.84 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.84 |
| Piotroski F-Score | 4 |